|
TW499412B
(en)
|
1996-11-26 |
2002-08-21 |
Dimensional Pharm Inc |
Aminoguanidines and alkoxyguanidines as protease inhibitors
|
|
CA2311969A1
(en)
|
1997-11-26 |
1999-06-03 |
3-Dimensional Pharmaceuticals, Inc. |
Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
|
|
US6344486B1
(en)
|
1998-04-03 |
2002-02-05 |
3-Dimensional Pharmaceuticals, Inc. |
Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
|
|
WO1999055355A1
(en)
|
1998-04-24 |
1999-11-04 |
3-Dimensional Pharmaceuticals, Inc. |
Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
|
|
SI1086122T1
(sl)
|
1998-06-11 |
2006-02-28 |
Pment L L C Johnson & Johnson |
Inhibitorji pirazinon-proteaze
|
|
FR2786181B1
(fr)
|
1998-11-24 |
2001-10-26 |
Hoechst Marion Roussel Inc |
Nouveaux derives d'iminoguanidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
|
|
WO2000038683A1
(en)
*
|
1998-12-23 |
2000-07-06 |
Du Pont Pharmaceuticals Company |
THROMBIN OR FACTOR Xa INHIBITORS
|
|
DE60005351D1
(de)
|
1999-07-09 |
2003-10-23 |
Dimensional Pharm Inc |
Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel
|
|
US6469029B1
(en)
|
1999-09-13 |
2002-10-22 |
3-Dimensional Pharmaceuticals, Inc. |
Azacycloalkanone serine protease inhibitors
|
|
JP2004504305A
(ja)
|
2000-07-17 |
2004-02-12 |
３−ディメンショナル ファーマシューティカルズ， インコーポレイテッド |
プロテアーゼインヒビターとしての環状オキシグアニジンピラジノン
|
|
US6635637B2
(en)
|
2000-08-04 |
2003-10-21 |
Dimensional Pharmaceuticals, Inc. |
Cyclic oxyguanidine protease inhibitors
|
|
US6486174B2
(en)
|
2000-08-07 |
2002-11-26 |
3-Dimensional Pharmaceuticals, Inc. |
Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
|
|
US6589504B1
(en)
*
|
2000-09-22 |
2003-07-08 |
Pharmacia & Upjohn Company |
Compounds and methods for diagnosing and treating amyloid-related conditions
|
|
CA2445160A1
(en)
*
|
2001-04-24 |
2002-10-31 |
Aryx Therapeutics |
Coumarin derivatives to be used as anticoagulants
|
|
EP1442012A1
(en)
|
2001-11-06 |
2004-08-04 |
Wyeth |
Process for the preparation of 2- alkyl(aryl)]sulfonylbenzene-sulfonyl chlorides and their intermediates
|
|
EP2982668A3
(en)
|
2002-12-03 |
2016-04-13 |
Pharmacyclics LLC |
2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors for the treatment of thromboembolic disorders
|
|
US7276608B2
(en)
*
|
2003-07-11 |
2007-10-02 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
|
US20070087061A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Medafor, Incorporated |
Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
|
|
US20070086958A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Medafor, Incorporated |
Formation of medically useful gels comprising microporous particles and methods of use
|
|
BRPI0718420A2
(pt)
|
2006-10-20 |
2013-11-12 |
Cpd Llc |
Método de restabelecimento do efeito da incretina
|
|
RU2353619C2
(ru)
*
|
2007-06-28 |
2009-04-27 |
Общество С Ограниченной Ответственностью "Бионика" |
Новые соединения, обладающие функцией антикоагулянтов, фармацевтические композиции на их основе для лечения тромботических состояний и плазмозамещающий раствор для коррекции гиперкоагуляционных нарушений при гемодилюции
|
|
RU2354647C2
(ru)
*
|
2007-06-28 |
2009-05-10 |
Общество С Ограниченной Ответственностью "Бионика" |
Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе
|
|
GB0815784D0
(en)
*
|
2008-08-29 |
2008-10-08 |
Xention Ltd |
Novel potassium channel blockers
|
|
US8894970B2
(en)
|
2010-12-31 |
2014-11-25 |
Corridor Pharmaceuticals, Inc. |
Arginase inhibitors and methods of use thereof
|
|
EP3209641A4
(en)
*
|
2014-05-05 |
2018-06-06 |
Lycera Corporation |
Benzenesulfonamido and related compounds for use as agonists of ror and the treatement of disease
|
|
WO2016073615A1
(en)
|
2014-11-07 |
2016-05-12 |
Regents Of The University Of Minnesota |
Salts and compositions useful for treating disease
|
|
CN110407721A
(zh)
*
|
2019-08-13 |
2019-11-05 |
上海毕得医药科技有限公司 |
一种4-氰基-3-(三氟甲基)苯-1-磺酰氯的合成方法
|